Anders Rylander, CEO will present at the Vator Securities Unicorn Summit in Stockholm on March 7, 2017. The presentation, part of the company’s planned IPO on Nasdaq First North in March 2017, is intended for investors. The purpose of the IPO is to raise funds to initiate the commercialization phase of the company’s DiviTum™ technology – a simple blood test that rapidly and reliably evaluates the response to therapy of patients with advanced breast cancer.

 

About the Unicorn Summit

Vator Securities Unicorn Summit is a capital markets day that attracts some of the most interesting and innovative business ventures in Sweden. As well as hearing company presentations, participants are offered a unique opportunity to network with industry peers and investors.

More information and registration will soon be available at www.vatorsecurities.se